BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2422885)

  • 1. Platelet membranes, eicosanoid biosynthesis and putative endogenous calcium ionophores.
    Carey F; Menashi S; Authi KS; Hack N; Lagarde M; Crawford N
    Adv Exp Med Biol; 1985; 192():185-99. PubMed ID: 2422885
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of lipoxygenase products in platelet function: relation to fatty acid modified phospholipids.
    Lagarde M; Croset M; Guichardant M; Dechavanne M
    Adv Exp Med Biol; 1985; 192():327-35. PubMed ID: 3938923
    [No Abstract]   [Full Text] [Related]  

  • 3. Arachidonic acid induces human platelet-fibrin retraction: the role of platelet cyclic endoperoxides.
    Di Minno G; Bertelé V; Cerletti C; de Gaetano G; Silver MJ
    Thromb Res; 1982 Feb; 25(4):299-306. PubMed ID: 6803385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibition of arachidonic acid metabolism in human platelets by RHC 80267, a diacylglycerol lipase inhibitor.
    Oglesby TD; Gorman RR
    Biochim Biophys Acta; 1984 Apr; 793(2):269-77. PubMed ID: 6424715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparative HPLC purification of prostaglandin endoperoxides and isolation of novel cyclooxygenase-derived arachidonic acid metabolites.
    Hecker M; Hatzelmann A; Ullrich V
    Biochem Pharmacol; 1987 Mar; 36(6):851-5. PubMed ID: 3105538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
    Brace LD; Venton DL; Le Breton GC
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H8-13. PubMed ID: 2409821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of lymphatic contractility by arachidonate metabolites.
    Johnston MG; Gordon JL
    Nature; 1981 Sep; 293(5830):294-7. PubMed ID: 7196995
    [No Abstract]   [Full Text] [Related]  

  • 8. Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
    Brace LD; Venton DL; Le Breton GC
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H1-7. PubMed ID: 3925795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor.
    Sato T; Hashizume T; Nakao K; Akiba S; Fujii T
    Biochim Biophys Acta; 1989 Aug; 992(2):168-73. PubMed ID: 2503041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat.
    Quilley J; McGiff JC; Nasjletti A
    Br J Pharmacol; 1989 Jan; 96(1):111-6. PubMed ID: 2522332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboxane A2 and the endoperoxides mediate canine platelet activation.
    Harris RH; Nichols R; Schmeling JW; Ramwell PW
    Thromb Res; 1981 Sep; 23(6):521-32. PubMed ID: 6798707
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of novel arachidonic acid metabolites formed by prostaglandin H synthase.
    Hecker M; Ullrich V; Fischer C; Meese CO
    Eur J Biochem; 1987 Nov; 169(1):113-23. PubMed ID: 3119336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinol induces platelet aggregation via activation of phospholipase A2.
    Nakano T; Hanasaki K; Matsumoto S; Arita H
    Biochem Biophys Res Commun; 1988 Aug; 154(3):1075-80. PubMed ID: 3408485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal vascular responsiveness to arachidonic acid in experimental diabetes.
    Quilley J; McGiff JC
    Br J Pharmacol; 1990 Jun; 100(2):336-40. PubMed ID: 2116203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets.
    Riendeau D; Guay J; Weech PK; Laliberté F; Yergey J; Li C; Desmarais S; Perrier H; Liu S; Nicoll-Griffith D
    J Biol Chem; 1994 Jun; 269(22):15619-24. PubMed ID: 8195210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the two pathways for arachidonate oxygenation in blood platelets.
    Dutilh CE; Haddeman E; Jouvenaz GH; Ten Hoor F; Nugteren DH
    Lipids; 1979 Feb; 14(2):241-6. PubMed ID: 34075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
    Vezza R; Mezzasoma AM; Venditti G; Gresele P
    Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues.
    Morinelli TA; Niewiarowski S; Kornecki E; Figures WR; Wachtfogel Y; Colman RW
    Blood; 1983 Jan; 61(1):41-9. PubMed ID: 6293626
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulmonary vascular responses to thromboxane A2 as unmasked by OKY-1581. A novel inhibitor of thromboxane synthesis.
    Kadowitz PJ; Nandiwada PA; Spannhake EW; Rosenson RS; McNamara DB; Hyman AL
    Chest; 1983 May; 83(5 Suppl):72S-74S. PubMed ID: 6404609
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclooxygenase dependent formation of 8-iso-prostaglandin F2 alpha by human platelets.
    Pratico D; Lawson JA; Fitzgerald GA
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():229-31. PubMed ID: 7732840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.